May 13, 2021 / 03:00PM GMT
Olivia Simone Brayer - BofA Securities, Research Division - Associate
All right. Good morning, everyone, and welcome to our final day of our BofA Virtual -- BofA Health Care Conference. My name is Olivia Brayer, and I'm on the U.S. biopharma team here at Bank of America. And we're very happy to have with us today, the CEO of Vanda Pharmaceuticals, Mihales Polymeropoulos. We did just launch on Vanda earlier this week, so let us know if you need our model or report. Happy to send either of those. But thanks so much for being with us today, Mihales.
Mihael H. Polymeropoulos - Vanda Pharmaceuticals Inc. - Founder, President, CEO & Director
Thank you, Olivia.
Olivia Simone Brayer - BofA Securities, Research Division - Associate
Yes. And just quickly before we begin, Vanda does have their latest corporate deck on the webcast. So feel free to check that out during the Q&A. You can also submit questions for Mihales and the Vanda team via the link.
Vanda Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot